IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BVF Inc

Q3 2019 Holdings

Filed 2019-11-14 | 59 holdings | $103.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Galapagos NV(GLPG)SPON ADR36315X101$46.6K305,0760.0%
AC Immune SA(ACIU)SHSH00263105$55.9K11,297,9110.1%
Ionis Pharmaceuticals Inc(IONS)COM462222100$56.0K935,5480.1%
Springworks Therapeutics IncCOM85205L107$61.7K2,844,1450.1%
Merus N VCOMN5749R100$82.7K4,639,4130.1%
Corvus Pharmaceuticals Inc(CRVS)COM221015100$9.2M3,047,1558.8%
Cytomx Therapeutics Inc(CTMX)COM23284F105$13.9M1,877,14813.3%
Arcus Biosciences Inc(RCUS)COM03969F109$32.6M3,579,02331.4%
Cytokinetics Inc(CYTK)COM NEW23282W605$47.4M4,165,55845.6%
PreviousPage 2 of 2